Gloria P. Gomez-Cardona
Antioquia, ANT, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
APOE3 Christchurch is associated with sphingolipids recycling and glial lipid remodeling in autosomal dominant Alzheimer's disease.
Journal: Research square
Published: July 29, 2026
Serum Lipidome as an Early Peripheral Indicator in Familial Alzheimer's Disease.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Upregulation of MAM by C99 disrupts ACSL4 activity and phospholipid homeostasis in Alzheimer's disease models.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 02, 2025
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevity.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 26, 2024
Differences in vocal brain areas and astrocytes between the house wren and the rufous-tailed hummingbird.
Journal: Frontiers in neuroanatomy
Published: November 15, 2023
BACE1 and SCD1 are associated with neurodegeneration.
Journal: Frontiers in aging neuroscience
Published: April 26, 2023
Obesity induces extracellular vesicle release from the endothelium as a contributor to brain damage after cerebral ischemia in rats.
Journal: Nutritional neuroscience
Published: August 30, 2022
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection.
Journal: Brain pathology (Zurich, Switzerland)
Published: January 21, 2022
Last Updated: 09/26/2026